What is he best known for?
The fields of study he is best known for:
- Organic chemistry
- Amino acid
- Biochemistry
His main research concerns Receptor, Pharmacology, GABAA receptor, GABAA-rho receptor and Biochemistry.
His research in Receptor tackles topics such as Endocrinology which are related to areas like Agonist, Long-term potentiation and Motor coordination.
His research integrates issues of Neurotransmitter, Mechanism of action, Function, Allosteric regulation and Binding site in his study of Pharmacology.
In GABAA receptor, Mary Chebib works on issues like Ginkgo biloba, which are connected to Bicuculline, Alpha and Competitive antagonist.
Mary Chebib combines subjects such as Endocannabinoid system, Ion channel and Cys-loop receptors with his study of GABAA-rho receptor.
He studied Antagonist and Stereochemistry that intersect with Acetylcholine receptor, Nicotinic agonist, Conotoxin and Cyclic peptide.
His most cited work include:
- The 'ABC' of GABA receptors: a brief review. (345 citations)
- GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology. (294 citations)
- Flavonoid modulation of GABA(A) receptors. (148 citations)
What are the main themes of his work throughout his whole career to date?
Mary Chebib spends much of his time researching Receptor, GABAA receptor, Pharmacology, Stereochemistry and GABAA-rho receptor.
His study on Receptor is covered under Biochemistry.
His study in GABAA receptor is interdisciplinary in nature, drawing from both gamma-Aminobutyric acid and Ionotropic effect.
His Pharmacology research includes themes of Benzodiazepine, Anxiolytic, Mechanism of action and Allosteric modulator, Allosteric regulation.
His work in Stereochemistry tackles topics such as Nicotinic agonist which are related to areas like Acetylcholine.
His GABAA-rho receptor study incorporates themes from Lipophilicity, Endocrinology and Class C GPCR.
He most often published in these fields:
- Receptor (60.65%)
- GABAA receptor (47.10%)
- Pharmacology (37.42%)
What were the highlights of his more recent work (between 2015-2021)?
- Receptor (60.65%)
- GABAA receptor (47.10%)
- Pharmacology (37.42%)
In recent papers he was focusing on the following fields of study:
Mary Chebib focuses on Receptor, GABAA receptor, Pharmacology, Biophysics and Binding site.
The study incorporates disciplines such as gamma-Aminobutyric acid and Homomeric in addition to GABAA receptor.
His Pharmacology study combines topics from a wide range of disciplines, such as Anticonvulsant, Flumazenil, Anxiolytic and Mechanism of action.
As part of his studies on Biophysics, Mary Chebib often connects relevant areas like Biochemistry.
The concepts of his Binding site study are interwoven with issues in Wittig reaction, Nitrile, Aldehyde, Tricyclic and IC50.
He has included themes like Cys-loop receptors, Class C GPCR, Function and Molecular neuroscience in his GABAA-rho receptor study.
Between 2015 and 2021, his most popular works were:
- GABAA Receptors and the Diversity in their Structure and Pharmacology. (73 citations)
- The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors. (57 citations)
- Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions. (39 citations)
In his most recent research, the most cited papers focused on:
- Organic chemistry
- Amino acid
- Biochemistry
GABAA receptor, Pharmacology, Receptor, GABAA-rho receptor and Ion channel are his primary areas of study.
His research in Pharmacology intersects with topics in Anticonvulsant, Flumazenil and Anxiolytic.
In general Receptor, his work in Allosteric regulation is often linked to Kainate receptor linking many areas of study.
His GABAA-rho receptor research includes elements of Homomeric, Biophysics, Class C GPCR and Molecular neuroscience.
In his study, GABAB receptor and Neuroscience is strongly linked to Binding site, which falls under the umbrella field of Ion channel.
The various areas that Mary Chebib examines in his Mechanism of action study include Agonist, Allosteric modulator and Nicotinic agonist.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
